𝔖 Bobbio Scriptorium
✦   LIBER   ✦

DOES TRIPLE THERAPY WITH CILOSTAZOL REDUCE THE RISK OF RESTENOSIS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION? INSIGHTS FROM A META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS

✍ Scribed by Amita Singh; Michael Fingerhood; Frederick Feit; Sripal Bangalore

Book ID
118582312
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
255 KB
Volume
59
Category
Article
ISSN
1558-3597

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A Randomized, Double-Blind, Multicenter
A Randomized, Double-Blind, Multicenter Comparison Study of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy to Reduce Restenosis After Drug-Eluting Stent Implantation in Long Coronary Lesions: Results From the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) Trial
✍ Seung-Whan Lee; Seong-Wook Park; Young-Hak Kim; Sung-Cheol Yun; Duk-Woo Park; Ch πŸ“‚ Article πŸ“… 2011 πŸ› Elsevier Science 🌐 English βš– 653 KB
Abciximab and angiographic restenosis af
Abciximab and angiographic restenosis after coronary stent placement. Analysis of the angiographic substudy of ISAR-REACTβ€”A double-blind, placebo-controlled, randomized trial evaluating abciximab in patients undergoing elective percutaneous coronary interventions after pretreatment with a high loading dose of clopidogrel
✍ Helmut SchΓΌhlen; Adnan Kastrati; Julinda Mehilli; JΓΆrg Hausleiter; Josef Dirschi πŸ“‚ Article πŸ“… 2006 πŸ› Elsevier Science 🌐 English βš– 163 KB